VS38c and CD38-multiepitope antibodies provide highly comparable minimal residual disease data in patients with multiple myeloma - Broijl, A; de Jong, A CM; van Duin, M; Sonneveld, P; Kühnau, J; van der Velden, V HJ (Am J Clin Pathol, 2022)